It is, perhaps, surprising that in spite of a large literature on prostate cancerscreening using PSA and its sub units there is a notable absence of studies thatpresent results that properly evaluate the performance of the screening tests,namely in terms of detection rates for given false-positive rates orvice versa. The gene discussed is KLK3; the disease is urogenital neoplasm.